PerkinElmer's Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection

(marketscreener.com) T-Cell Select reagent kit simplifies the T-SPOT.TB test laboratory workflow through automation expanding access to the most sensitive latent TB test on the markethttps://www.marketscreener.com/quote/stock/PERKINELMER-INC-12426/news/PerkinElmer-s-Oxford-Immunotec-Receives-U-S-FDA-Approval-for-T-Cell-Select-to-Automate-Clinically-S-41835702/?utm_medium=RSS&utm_content=20220922